The effect of boswellia largely depends on exactly how you take it: which dose to choose, when to take it relative to food and how long to wait for a result. The editorial team has gathered practical answers, relying on the doses and regimens used in clinical studies of standardized extracts.
What the dosage depends on
The main rule: the dose of boswellia cannot be defined "in milligrams of resin" without taking into account the type of product. Raw resin, a standardized extract with 65% boswellic acids, and a concentrate enriched with AKBA to 30% are three different products, and their effective doses differ by several times.
Therefore the first thing to do is to read the label carefully. A quality manufacturer indicates how many milligrams of extract are contained in a capsule, to what content of boswellic acids and/or AKBA it is standardized, and often the name of the patented extract that was clinically studied.
If the package indicates only "boswellia resin powder" without standardization, it is impossible to estimate the real dose of active substances. The editorial team does not recommend such products for targeted use.
The goal is also important. Most data have been obtained for chronic joint pain in osteoarthritis, so these doses can be considered a reference point. For other purposes there are no reliable recommendations.
Doses used in studies
Below are the doses that were used in published clinical studies. They are not an individual recommendation but give an idea of the range in which efficacy and safety were evaluated.
| Product type | Daily dose in studies | Duration | Source |
|---|---|---|---|
| Standardized B. serrata extract | ~1000 mg (333 mg three times a day) | 8 weeks | Kimmatkar et al., 2003 |
| 5-Loxin (AKBA-enriched ~30%) | 100 or 250 mg | 90 days | Sengupta et al., 2008 |
| Aflapin | 100 mg | 30 days | Vishal et al., 2011 |
| B. serrata resin (asthma) | 300 mg three times a day | 6 weeks | Gupta et al., 1998 |
As can be seen, for AKBA-enriched extracts the effective doses are much lower than for classic standardized ones. This is logical: a smaller mass contains more of the most active acid.
In the study by Sengupta and colleagues, the higher dose of 5-Loxin (250 mg) gave a somewhat greater effect than 100 mg, which indicates dose dependence. However, increasing the dose beyond the studied values has no confirmed benefit and may increase the risk of stomach reactions.
A practical approach is to follow the dose indicated by the manufacturer for the specific clinically studied extract and not to exceed it without a doctor's approval.
When to take it: the role of food
Boswellic acids are fat-soluble compounds with low bioavailability. The study by Sterk and colleagues (2004) on healthy volunteers showed that taking the extract together with a high-calorie fatty meal substantially increased the concentrations of boswellic acids in plasma compared with taking it on an empty stomach.
Hence the practical advice: take boswellia during a main meal that contains fats - for example, at lunch or dinner. This simultaneously reduces the likelihood of heartburn and nausea.
The time of day itself, judging by the available data, is not critical. Regularity and the tie to food are more important. For athletes there is no evidence of an advantage of taking it before or after training.
Since the half-life of boswellic acids is relatively short, in many studies the daily dose was divided into two or three intakes. For highly active enriched extracts, one or two intakes a day are often sufficient.
Course duration and evaluation of the result
Boswellia is not a fast-acting painkiller. In most studies, improvement on pain and function scales became noticeable after a few weeks, and the maximum effect was recorded at the end of the 8-12-week period. For Aflapin an earlier onset of action was reported, but this is data from a single research group.
The editorial team suggests the following approach to evaluation: before starting intake, record your pain level on a scale from 0 to 10 and a few functional indicators - for example, whether the knee hurts when going down stairs or after training. Repeat the assessment after 4 and 8 weeks.
If after 8-12 weeks of regular intake there is no noticeable improvement, there is no point in continuing. If there is an effect, you can discuss long-term use or courses with breaks with your doctor.
- Weeks 1-2:getting used to it, assessing tolerability, especially on the part of the stomach.
- Week 4:the first interim assessment of pain and function.
- Weeks 8-12:the final assessment of efficacy; the decision to continue or discontinue.
Data on the safety of intake beyond six months are limited. Therefore, with long-term use it is reasonable to take periodic breaks and to check baseline tests annually, in particular liver function tests.
Common mistakes when taking it
The first mistake is taking it on an empty stomach, especially in the morning with coffee. This reduces absorption and increases the risk of stomach discomfort.
The second is irregularity. Taking it "when it hurts" does not correspond to the regimens in which boswellia showed an effect: in studies it was taken daily for weeks.
The third is expecting quick pain relief and increasing the dose on one's own. If the pain is acute or worsening, diagnosis is needed, not doubling the number of capsules.
The fourth is the simultaneous use of several boswellia products, for example a separate supplement and a "joint complex" that already contains it. This makes it easy to imperceptibly exceed the dose.
Editorial conclusions
The dosage of boswellia depends on the type of extract: for classic standardized products, studies used about 1 g per day; for AKBA-enriched ones, 100-250 mg.
It is better to take the supplement with a meal that contains fats: this improves absorption and reduces stomach symptoms. The daily dose is often divided into several intakes.
The effect develops gradually, so it is worth evaluating the result after 8-12 weeks of regular intake, and discontinuing it if there is no benefit.
We also recommend reading our articles "Boswellia: dosage forms and which to choose", "Side effects of Boswellia" and "What to combine Boswellia with".
References
- Kimmatkar N, Thawani V, Hingorani L, Khiyani R. Efficacy and tolerability of Boswellia serrata extract in treatment of osteoarthritis of knee – a randomized double blind placebo controlled trial. Phytomedicine. 2003;10(1):3–7.
- Sengupta K, Alluri KV, Satish AR, et al. A double blind, randomized, placebo controlled study of the efficacy and safety of 5-Loxin for treatment of osteoarthritis of the knee. Arthritis Res Ther. 2008;10(4):R85.
- Vishal AA, Mishra A, Raychaudhuri SP. A double blind, randomized, placebo controlled clinical study evaluates the early efficacy of Aflapin in subjects with osteoarthritis of knee. Int J Med Sci. 2011;8(7):615–622.
- Gupta I, Gupta V, Parihar A, et al. Effects of Boswellia serrata gum resin in patients with bronchial asthma: results of a double-blind, placebo-controlled, 6-week clinical study. Eur J Med Res. 1998;3(11):511–514.
- Sterk V, Büchele B, Simmet T. Effect of food intake on the bioavailability of boswellic acids from a herbal preparation in healthy volunteers. Planta Med. 2004;70(12):1155–1160.
- Yu G, Xiang W, Zhang T, et al. Effectiveness of Boswellia and Boswellia extract for osteoarthritis patients: a systematic review and meta-analysis. BMC Complement Med Ther. 2020;20(1):225.
- Siddiqui MZ. Boswellia serrata, a potential antiinflammatory agent: an overview. Indian J Pharm Sci. 2011;73(3):255–261.
Andriy Melnyk
A strength-sports coach and author of programs for beginner and intermediate levels. Writes about training planning.
